Who can take part in a clinical trial
This page tells you about the entry conditions for trials. There is information about
Entry conditions
Researchers call the entry conditions for trials 'eligibility criteria'. Trials have these to make sure that the patients taking part are as similar as possible. That way, if one group does better than the other, the researchers can be sure it was due to a difference in treatment. And not because their cancer was at a different stage for example.
Eligibility criteria are clearly written in the trial protocol . Common entry criteria include the categories listed on this page.
Type of cancer
Many trials are only open to people with a particular type of cancer. This is because doctors and researchers are usually trying to find out if a treatment works for a single type of cancer. Cancers are different and a treatment that works for one cancer may not work for another.
Some trials are open to two cancers that respond to treatment in the same way, such as stomach cancer and food pipe (oesophageal) cancer. Some trials, particularly phase 1 trials, may be open to people with different types of cancer.
Stage of cancer
The stage of a cancer tells you how big it is and whether it has spread. Many trials are only open to people with a particular stage of cancer.
Previous treatment
This is an important condition for trial entry. A trial protocol may say you can't enter if you've had a particular type of treatment before. Some trials say that you can't take part if you are having another treatment at the same time as being in the trial. Or the protocol may say you must have had a particular treatment already.
You often need to have had the standard treatment for your cancer type to take part in a trial of a new treatment. It is important you have had proven treatments before taking part in a trial of new treatments that aren’t proven to work yet.
Age
This is usually a very wide range for adult treatment trials. It is usually there to make sure everyone in the trial is over 18. There are specific trials for children.
Some adult trials have an upper age limit. This will be for treatments that are tough to get through, such as high dose chemotherapy trials. Sometimes trials look at treatment for older people, so you may need to be older than 65 or 70 to take part. They may be looking at a less intensive alternative to the standard treatment for a particular cancer.
General health (performance status)
When describing a person's general health, trial protocols usually call it performance status. Doctors use a scale to grade how well you are.
There are different versions. The Eastern Cooperative Oncology Group (ECOG) and World Health Organisation (WHO) scale is the most commonly used. Many trial protocols may say they are open to people who have particular performance status, for example 0–2. This is because you must be well enough to cope with extra hospital visits and tests. And for treatment trials you must be well enough to cope with any known or unknown side effects.
- 0 – you are fully active, more or less as you were before your illness
- 1 – you can't carry out heavy physical work, but can do anything else
- 2 – you are up and about more than half the day, you can look after yourself but can't work
- 3 – you are in bed or a chair for more than half the day, you need help to look after yourself
- 4 – you are in bed or a chair all the time and need complete care
Karnofsky performance status is another commonly used scale. It is similar to the WHO scale, but goes to up 100.
- 100 – you don’t have any evidence of disease and feel well
- 90 – you only have minor signs or symptoms but can carry on as normal
- 80 – you have some signs or symptoms and it takes a bit of effort to carry on as normal
- 70 – you can care for yourself but can’t carry on with all your normal activities or do active work
- 60 – you need help from time to time but can mostly care for yourself
- 50 – you need quite a lot of help to care for yourself
- 40 – you always need help to care for yourself
- 30 – you are disabled and may need to stay in hospital
- 20 – you are ill, in hospital and need a lot of treatment
- 10 – you are very ill and unlikely to recover
The Lansky scale is used for children.
- 100 – the child is fully active, normal
- 90 – the child has minor restrictions in strenuous physical activity
- 80 –the child is active, but tires more quickly than usual
- 70 – they can't play as energetically as normal and spend less time than usual in play activity
- 60 – the child is up and around, but active play is minimal – they keep busy by being involved in quieter activities
- 50 – the child needs to lie down for much of the day but gets dressed – they don’t actively play but take part in quiet play and activities
- 40 – they are mainly in bed but take part in quiet activities
- 30 – they can't get out of bed and need help even for quiet play
- 20 – the child sleeps often and play is completely limited to very passive activities
- 10 – they don’t play or get out of bed
- 0 – the child doesn't respond at all
Other medical conditions and life expectancy
A few trials (usually those for an early stage of cancer) say that patients must have a life expectancy of more than a particular number of years – for example, 5 or 10 years. This is really a way of excluding people with other life threatening conditions, such as severe heart problems.
It seems harsh to use life expectancy to exclude people from a trial. But researchers won't get the results they need if a large proportion of their trial patients die of something else before the trial of the cancer treatment ends.
You may not be able to take part in a trial if you have a particular illness, even if it isn't life threatening. For example, if you have a heart condition, you may not be able to join a trial testing a drug that could have heart related side effects. Again, this seems hard, but the researchers may not be able to sort out the effects of the drug from the effects of your heart condition. And they will be worried about possibly putting you at risk of harm.
Related information
We have information about
New review due:1 February 2025
Last reviewed
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Search for clinical trials
Use our search page to find a trial by cancer type, drug name or trial name